Cardinal Capital Management Novartis Ag Transaction History

Cardinal Capital Management

  • $582 Million
  • Q2 2024

A detailed history of Cardinal Capital Management transactions in Novartis Ag stock. As of the latest transaction made, Cardinal Capital Management holds 46,875 shares of NVS stock, worth $5.34 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares
46,875
Previous 45,719 2.53%
Holding current value
$5.34 Million
Previous $4.42 Million 12.84%
% of portfolio
0.86%
Previous 0.73%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024
BUY
$92.57 - $107.37 $107,010 - $124,119
1,156 Added 2.53%
46,875 $4.99 Million
Q1 2024

Jul 12, 2024
BUY
$95.27 - $108.47 $368,694 - $419,778
3,870 Added 9.25%
45,719 $4.42 Million
Q1 2024

Apr 15, 2024
BUY
$95.27 - $108.47 $368,694 - $419,778
3,870 Added 9.25%
45,719 $4.42 Million
Q4 2023

Jul 12, 2024
BUY
$92.27 - $101.54 $14,209 - $15,637
154 Added 0.37%
41,849 $4.23 Million
Q4 2023

Jan 26, 2024
BUY
$92.27 - $101.54 $14,209 - $15,637
154 Added 0.37%
41,849 $4.23 Million
Q3 2023

Jul 12, 2024
BUY
$94.73 - $105.13 $77,299 - $85,786
816 Added 2.0%
41,695 $4.25 Million
Q3 2023

Oct 16, 2023
BUY
$94.73 - $105.13 $77,299 - $85,786
816 Added 2.0%
41,695 $4.25 Million
Q2 2023

Jul 12, 2024
SELL
$92.52 - $104.91 $447,796 - $507,764
-4,840 Reduced 10.59%
40,879 $4.13 Million
Q2 2023

Jul 12, 2023
SELL
$92.52 - $104.91 $52,181 - $59,169
-564 Reduced 1.36%
40,879 $4.13 Million
Q1 2023

Apr 18, 2023
SELL
$80.03 - $92.81 $8,003 - $9,281
-100 Reduced 0.24%
41,443 $3.81 Million
Q4 2022

Jan 20, 2023
SELL
$75.55 - $92.52 $22,438 - $27,478
-297 Reduced 0.71%
41,543 $0
Q3 2022

Oct 21, 2022
SELL
$74.61 - $87.26 $40,737 - $47,643
-546 Reduced 1.29%
41,840 $3.18 Million
Q2 2022

Aug 04, 2022
BUY
$80.52 - $93.75 $20,130 - $23,437
250 Added 0.59%
42,386 $3.58 Million
Q1 2022

Apr 21, 2022
BUY
$80.11 - $90.62 $129,377 - $146,351
1,615 Added 3.99%
42,136 $3.7 Million
Q4 2021

Jan 18, 2022
BUY
$79.7 - $88.13 $13,469 - $14,893
169 Added 0.42%
40,521 $3.54 Million
Q3 2021

Oct 21, 2021
BUY
$81.78 - $95.14 $11,367 - $13,224
139 Added 0.35%
40,352 $3.3 Million
Q2 2021

Jul 14, 2021
BUY
$85.24 - $94.15 $39,721 - $43,873
466 Added 1.17%
40,213 $3.67 Million
Q1 2021

Apr 19, 2021
BUY
$83.5 - $98.47 $65,881 - $77,692
789 Added 2.03%
39,747 $3.4 Million
Q4 2020

Feb 01, 2021
BUY
$78.07 - $94.43 $63,236 - $76,488
810 Added 2.12%
38,958 $3.68 Million
Q3 2020

Oct 16, 2020
BUY
$82.14 - $91.0 $24,559 - $27,209
299 Added 0.79%
38,148 $3.32 Million
Q2 2020

Jul 16, 2020
SELL
$80.93 - $91.1 $445,357 - $501,323
-5,503 Reduced 12.69%
37,849 $3.31 Million
Q1 2020

Apr 20, 2020
SELL
$70.67 - $99.01 $21,907 - $30,693
-310 Reduced 0.71%
43,352 $3.57 Million
Q4 2019

Jan 21, 2020
SELL
$84.35 - $95.37 $22,774 - $25,749
-270 Reduced 0.61%
43,662 $4.13 Million
Q3 2019

Oct 18, 2019
BUY
$85.54 - $94.26 $684 - $754
8 Added 0.02%
43,932 $3.82 Million
Q2 2019

Jul 08, 2019
SELL
$75.4 - $92.8 $19,981 - $24,592
-265 Reduced 0.6%
43,924 $4.01 Million
Q1 2019

Apr 11, 2019
BUY
$75.32 - $86.15 $19,055 - $21,795
253 Added 0.58%
44,189 $4.25 Million
Q4 2018

Jan 15, 2019
BUY
$73.66 - $82.02 $54,434 - $60,612
739 Added 1.71%
43,936 $3.77 Million
Q3 2018

Oct 25, 2018
BUY
$66.94 - $77.43 $2,075 - $2,400
31 Added 0.07%
43,197 $3.72 Million
Q2 2018

Jul 25, 2018
BUY
$64.91 - $73.36 $15,773 - $17,826
243 Added 0.57%
43,166 $3.26 Million
Q1 2018

Apr 25, 2018
BUY
$70.39 - $84.15 $18,231 - $21,794
259 Added 0.61%
42,923 $3.47 Million
Q4 2017

Feb 01, 2018
SELL
$72.33 - $77.64 $4,556 - $4,891
-63 Reduced 0.15%
42,664 $3.58 Million
Q3 2017

Oct 24, 2017
BUY
$74.14 - $77.27 $3.17 Million - $3.3 Million
42,727
42,727 $3.67 Million

Others Institutions Holding NVS

# of Institutions
1,426
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.54M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $245B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cardinal Capital Management Portfolio

Follow Cardinal Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cardinal Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Cardinal Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email